Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Merrimack Pharmaceuticals Inc.
DescriptionSingle fusion polypeptide comprised of an immunoglobulin G1 (IgG1) Fc region followed by three successive tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) monomers connected by two fifteen-amino acid linkers
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today